Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin

Japanese Journal of Cancer Research

Volumn 92, Issue 3, 2001, Pages 249-256

  Nakatani, Tamaki ^a,b   Roy, Goutam ^a   Fujimoto, Nariaki ^a   Asahara, Toshimasa ^b   Ito, Akihiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

DEN; Leuprorelin; Liver tumor; Mice; Testosterone

Indexed keywords

ANTIANDROGEN; ANTIESTROGEN; BROXURIDINE; DIETHYLNITROSAMINE; ESTRADIOL; FLUTAMIDE; GONADOTROPIN; LEUPRORELIN; SEX HORMONE; TAMOXIFEN DERIVATIVE; TESTOSTERONE; TOREMIFENE;

ADOLESCENT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG IMPLANTATION; DRUG PELLET; FEMALE; GENDER; HORMONE RESPONSE; INCIDENCE; LIVER TUMOR; MALE; MITOSIS INDEX; MOUSE; NEWBORN; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PARAMETER; PREVALENCE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BODY WEIGHT; CROSSES, GENETIC; DIETHYLNITROSAMINE; ESTRADIOL; FEMALE; LEUPROLIDE; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MITOTIC INDEX; ORGAN SIZE; OVARIECTOMY; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 0035066739     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01089.x     Document Type: Article

References (42)

1. Epidemiological characteristics and risk factors of hepatocellular carcinoma
2. Cancer incidence and incidence rates in Japan in 1992-1993: Estimates based on data from seven population-based cancer registries
3. Hepatocellular carcinoma. A worldwide problem and the major risk factors
4. Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine
5. Modifying role of partial hepactectomy and gonadectomy in ethylnitrosourea-induced hepatocarcinogenesis
6. Relevance of basophilic foci to promoting effect of sex hormones on hepatocarcinogenesis
7. 1 mouse liver
8. Heterogeneity in androgen receptor levels and growth response to dihydrotestosterone in sublines derived from human hepatocellular carcinoma line (KYN-1)
9. Effects of castration and androgen replacement on tumor growth of human hepatocellular carcinoma in nude mice
10. Antitumor effect of controlled release formulation of leuprorelin acetate (Leuplin) in DMBA (dimethylbenzanthracene)-induced mammary tumors in rats
11. The direct extra-pituitary actions of controlled release formulation of leuprorelin acetate (Leuplin)
12. Primary endocrine therapy as pre- and perimenopausal metastatic breast carcinoma with leuprorelin acetate depot
13. Leuprorelin three-month depot in the treatment of advanced and metastatic prostate cancer: Long-term follow-up results
14. Effectiveness and tolerance of three month sustained release leuprorelin in the treatment of metastatic prostatic cancer (comparative, randomized, multicentric study)
15. Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5α-dihydrotestosterone
16. Androgen and estrogen receptors in hepatocellular carcinoma and surrounding liver in women
17. Phase II study of flutamide in the treatment of hepatocellular carcinoma
18. Leuproide acetate prevents toxic effects of cisplatin on the kidneys and gastrointestinal tract
19. Regression of rat mammary tumors effected by a gonadoliberin analog
20. Regression of rat mammary tumors by a potent luteinizing hormone releasing hormone (Leuprolide) administered vaginally
21. Gonadotropin-releasing hormone antagonist administration enhances gonadotropin responsiveness at doses inadequate to suppress immunoassayable gonadotropin levels
22. Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats
23. Genetic variation in liver tumor susceptibility, plasma testosterone levels, and androgen receptor binding in six inbred strains of mice
24. Evaluation of hepatocellular neoplasm in mice
25. 1 mouse liver tumors
26. Strain specific sensitivity to diethylnitorosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN ↔ C57BL/6N chimeric mice
27. On the obligatory role of the hypophysis in sexual differentiation of hepatic metabolism in rats
28. Physiological and biochemical reviews of sex differences and carcinogenesis with particular reference to the liver
29. The effect of several sex steroid hormones on the growth rate of three Morris hepatoma tumor lines
30. Importance of testes in induction of hyperplastic nodules, carcinomas, and cirrhosis of liver AxC male rats ingesting 0.025% N-2-fluorenyldiacetamide
31. Aflatoxin carcinogenesis: Inhibition of liver cancer induction in hypophysectomized rats
32. 1 in rats
33. Hormonal manipulation of human hepatocellular carcinoma: A clinical investigation and therapeutic opportunity
34. Hormonal treatment of hepatocellular carcinoma
35. Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5α-dihydrotestosterone
36. Effect of D-tryptophan-6-luteinizing hormone-releasing hormone on the tumoral growth and plasma sex steroid levels in cirrhotic patients with hepatocellular carcinoma
37. Failure of ketoconazole as anti-androgen therapy in non-resectable primary hepatocellular carcinoma
38. Genetic variation in liver tumor susceptibility, plasma testosterone levels and androgen receptor binding in six inbred strains of mice
39. The androgen receptor and liver tumor development in mice
40. 252Cf neutron-induced liver tumors in mice
41. 1 mice
42. Active cell death in hormone-dependent tissue